Page 35 - JCTR-10-1
P. 35
Shah et al. | Journal of Clinical and Translational Research 2024; 10(1): 25-32 31
5. Conclusions [5] Danan G, Teschke R. RUCAM in Drug and Herb Induced
Liver Injury: The Update. Int J Mol Sci 2015;17:14.
A short course (a few weeks) of steroids can be used to
effectively treat DILI and intractable pruritus in patients without doi: 10.3390/ijms17010014
liver failure. However, large prospective controlled studies are [6] Bent S, Ko R. Commonly Used Herbal Medicines in the
needed to confirm the role of corticosteroids in these situations. United States: A Review. Am J Med 2004;116:478-85.
doi: 10.1016/j.amjmed.2003.10.036
Acknowledgments [7] Philips CA, Paramaguru R, Joy AK, Antony KL,
None. Augustine P. Clinical Outcomes, Histopathological
Patterns, and Chemical Analysis of Ayurveda and
Funding Herbal Medicine Associated with Severe Liver Injury-A
None. Single-center Experience from Southern India. Indian J
Gastroenterol 2018;37:9-17.
Conflicts of Interest doi: 10.1007/s12664-017-0815-8
The authors declare no conflicts of interest. [8] Navarro VJ, Barnhart H, Bonkovsky HL, Davern T,
Fontana RJ, Grant L, et al. Liver Injury from Herbals
Ethics Approval and Consent to Participate and Dietary Supplements in the U.S. Drug-induced Liver
Injury Network. Hepatology 2014;60:1399-408.
As this study was retrospective in nature, research ethics
approval was not obtained. However, written informed consent doi: 10.1002/hep.27317
was obtained from all patients for inclusion in the study. [9] Petrovic A, Vukadin S, Sikora R, Bojanic K, Smolic R,
Plavec D, et al. Anabolic Androgenic Steroid-induced Liver
Consent for Publication Injury: An Update. World J Gastroenterol 2022;28:3071-80.
Written informed consent was obtained from all patients for doi: 10.3748/wjg.v28.i26.3071
using their data in a publication. [10] Devarbhavi H, Raj S, Joseph T, Singh R, Patil M. Features
and Treatment of Dapsone-induced Hepatitis, based
Availability of data on Analysis of 44 Cases and Literature Review. Clin
Data are available from the corresponding author on reasonable Gastroenterol Hepatol 2017;15:1805-7.
request. doi: 10.1016/j.cgh.2017.05.031
[11] Zhou ZX, Yin XD, Zhang Y, Shao QH, Mao XY, Hu WJ,
References et al. Antifungal Drugs and Drug-induced Liver Injury:
[1] Chalasani NP, Maddur H, Russo MW, Wong RJ, Reddy KR, A Real-World Study Leveraging the FDA Adverse
Practice Parameters Committee of the American College of Event Reporting System Database. Front Pharmacol
Gastroenterology. ACG Clinical Guideline: Diagnosis and 2022;13:891336.
Management of Idiosyncratic Drug-induced Liver Injury. doi: 10.3389/fphar.2022.891336
Am J Gastroenterol 2021;116:878-98. [12] Raschi E, Poluzzi E, Koci A, Caraceni P, De Ponti F.
doi: 10.14309/ajg.0000000000001259 Assessing Liver Injury Associated with Antimycotics:
[2] Devarbhavi H. Drug-induced Liver Injury Unique to India. Concise Literature Review and Clues from Data Mining of
Clin Liver Dis (Hoboken) 2021;18:108-10. the FAERS Database. World J Hepatol 2014;6:601-12.
doi: 10.1002/cld.1120 doi: 10.4254/wjh.v6.i8.601
[3] Brahmer JR, Lacchetti C, Schneider BJ, Atkins MB, [13] Sandhu N, Navarro V. Drug-induced Liver Injury in GI
Brassil KJ, Caterino JM, et al. Management of Immune- Practice. Hepatol Commun 2020;4:631-45.
related Adverse Events in Patients Treated with Immune doi: 10.1002/hep4.1503
Checkpoint Inhibitor Therapy: American Society of [14] Andrade RJ, Chalasani N, Björnsson ES, Suzuki A, Kullak-
Clinical Oncology Clinical Practice Guideline. J Clin Ublick GA, Watkins PB, et al. Drug-induced Liver Injury.
Oncol 2018;36:1714-68. Nat Rev Dis Primers 2019;5:58.
doi: 10.1200/JCO.2017.77.6385 doi: 10.1038/s41572-019-0105-0
[4] Björnsson ES, Bergmann O, Jonasson JG, Grondal G, [15] European Association for the Study of the Liver, Clinical
Gudbjornsson B, Olafsson S. Drug-induced Autoimmune Practice Guidelines Panel, Wendon J, Panel Members,
Hepatitis: Response to Corticosteroids and Lack of Relapse Cordoba J, Dhawan A, et al. EASL Clinical Practical
After Cessation of Steroids. Clin Gastroenterol Hepatol Guidelines on the Management of Acute (Fulminant) Liver
2017;15:1635-6. Failure. J Hepatol 2017;66:1047-81.
doi: 10.1016/j.cgh.2017.05.027 doi: 10.1016/j.jhep.2016.12.003
DOI: https://doi.org/10.36922/jctr.00104

